Agent for preventing or treating neuropathy

Details Agent for preventing or treating neuropathy Agent for preventing or treating neuropathy

2003-10-30

2008-09-09

Anderson, Rebecca L (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07423159

ABSTRACT:
The present invention provides an agent for preventing or treating neuropathy having superior action and low toxicity. This agent comprises a compound represented by the formula: wherein ring A is a 5-membered aromatic heterocycle containing 2 or more nitrogen atoms, which may further have substituent(s); B is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group; X is a divalent acyclic hydrocarbon group; Z is —O—, —S—, —NR2—, —CONR2— or —NR2CO— (R2is a hydrogen atom or an optionally substituted alkyl group); Y is a bond or a divalent acyclic hydrocarbon group; R1is an optionally substituted cyclic group, an optionally substituted amino group or an optionally substituted acyl group, provided that when the 5-membered aromatic heterocycle represented by ring A is imidazole, then Z should not be —O—, or a salt thereof.

REFERENCES:
patent: 3702330 (1972-11-01), Hoff et al.
patent: 4172136 (1979-10-01), Berger et al.
patent: 4447444 (1984-05-01), Stahler et al.
patent: 4835280 (1989-05-01), Martens et al.
patent: 5250504 (1993-10-01), Maravetz
patent: 5464860 (1995-11-01), Lepage et al.
patent: 5552420 (1996-09-01), Aldous et al.
patent: 2004/0204417 (2004-10-01), Perez et al.
patent: 0 153 850 (1985-09-01), None
patent: 0 630 894 (1994-12-01), None
patent: 1 148 053 (2001-10-01), None
patent: 4-184435 (1992-07-01), None
patent: 86/00307 (1986-01-01), None
patent: 00/01679 (2000-01-01), None
patent: 00/75120 (2000-12-01), None
patent: 01/14372 (2001-03-01), None
patent: 02/098852 (2002-12-01), None
patent: 03/049702 (2003-06-01), None
patent: 03/072554 (2003-09-01), None
patent: 2003/099793 (2003-12-01), None
T. M. Monteiro et al., “Synthesis and analgesic activity of new pyrazole-4-carboxanilides and (E)-3-pyrazol-4-ylpropenanilides”, Revista Portuguesa De Farmacia, vol. 49, No. 4, 1999, pp. 153-160, with English translation.
M. K. Bratenko et al., “Functionally Substituted 3-Heterylpyrazoles: XI. 3-[3-Aryl (heteryl)pyrazol-4-yl]propenoic and Propanoic Acids”, Russian Journal of Organic Chemistry, vol. 38, No. 8, 2002, pp. 1171-1177.
Patent Abstracts of Japan, vol. 1998, No. 12, Oct. 31, 1998 & JP 10 195063 A, Jul. 28, 1998 *abstract*.
M. Ohta et al., “Novel 5-Hydroxytryptamine (5-HT3) Receptor Antagonists. I. Synthesis and Structure-Activity Relationships of Conformationally Restricted Fused Imidazole Derivatives” Chem. Phar. Bull. vol. 44, No. 5, 1996, pp. 991-999.
Y. Yuen-Lang et al., “Chemotherapeutic Studies on Schistosomiasis XXXIII. Synthesis of β-(5-Nitroimidazol-2-YI) Acrylamides and Related Compounds”, Pharmaceutical Industry, vol. 17, No. 10, 1986, pp. 444-448, with English translation.
Y. Z. Ling et al., “17-Imidazolyl, Pyrazolyl, and Isoxazolyl Androstene Derivatives. Novel Steroidal Inhibitors of Human Cytochrome C17,20-Lyase (P45017a)”, J. Med. Chem., vol. 40, No. 20, Sep. 26, 1997, pp. 3297-3304.
R. Plate et al., “Synthesis and Muscarinic Activities of 3-(Pyrazolyl)-1,2,5,6-tetrahydropyridine Derivatives”, Bioorganic & Medicinal Chemistry, vol. 4, No. 2, Feb. 1996, pp. 227-237.
C. S. Lee et al., “Carbon-Carbon Linked (Pyrazolylphenyl)oxazolidinones with Antibacterial Activity Against Multiple Drug Resistant Gram-Positive and Fastidious Gram-Negative Bacteria”, Bioorganic & Medicinal Chemistry, vol. 9, No. 12, Dec. 2001, pp. 3243-3253.
R. Plate et al., “Synthesis and In Vitro Muscarinic Activities of a Series of 3-(Pyrazol-3-yl)-1-azabicyclo[2.2.2]octanes”, Bioorganic & Medicinal Chemistry, vol. 8, No. 2, Feb. 2000, pp. 449-454.
R. W. Harper et al., “Leukotriene B4(LTB4) Receptor Antagonists: A Series of (Hydroxyphenyl)pyrazoles”, J. Med. Chem., vol. 37, No. 15, Jul. 22, 1994, pp. 2411-2420.
G. R. Bebernitz et al., “The Effect of 1,3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice”, J. Med. Chem., vol. 44, 2001, pp. 2601-2611.
Russian Office Action issued Jul. 16, 2007 in the corresponding Russian Application No. 2005-116689 with English translation.
“Heterocyclic compounds” ed. R.Elderfield, M. Foreign Literature, 1954, v.V, 9.45-47 In Russian with English translation.

Affiliated with

Also associated with

Rating

Agent for preventing or treating neuropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for preventing or treating neuropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for preventing or treating neuropathy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3987876